These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21641347)

  • 1. Prognostic value of cardiac troponin T in patients with moderate to severe heart failure scheduled for cardiac resynchronization therapy.
    Aarones M; Gullestad L; Aakhus S; Ueland T; Skaardal R; Aass H; Wergeland R; Smith HJ; Aukrust P; Kongsgaard E
    Am Heart J; 2011 Jun; 161(6):1031-7. PubMed ID: 21641347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure.
    Latini R; Masson S; Anand IS; Missov E; Carlson M; Vago T; Angelici L; Barlera S; Parrinello G; Maggioni AP; Tognoni G; Cohn JN;
    Circulation; 2007 Sep; 116(11):1242-9. PubMed ID: 17698733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and sustained effects of cardiac resynchronization therapy on N-terminal pro-B-type natriuretic peptide in patients with moderate to severe heart failure and cardiac dyssynchrony.
    Fruhwald FM; Fahrleitner-Pammer A; Berger R; Leyva F; Freemantle N; Erdmann E; Gras D; Kappenberger L; Tavazzi L; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jul; 28(13):1592-7. PubMed ID: 17298973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined dyssynchrony and scar imaging with cardiac magnetic resonance imaging predicts clinical response and long-term prognosis following cardiac resynchronization therapy.
    Taylor AJ; Elsik M; Broughton A; Cherayath J; Leet A; Wong C; Iles L; Butler M; Pfluger H
    Europace; 2010 May; 12(5):708-13. PubMed ID: 20190262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Usefulness of N-terminal Prohormone of Brain Natriuretic Peptide and High Sensitivity Troponin T in Patients with Heart Failure Undergoing Cardiac Resynchronization Therapy.
    Debska-Kozlowska A; Ksiazczyk M; Warchol I; Lubinski A
    Curr Pharm Des; 2019; 25(14):1671-1678. PubMed ID: 31223080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of early combined N-terminal pro-brain natriuretic peptide and cardiac troponin T measurements for long-term risk stratification of patients with decompensated heart failure.
    Perna ER; Macin SM; Cimbaro Canella JP; Szyszko A; Franciosi V; Vargas Morales W; Bayol AP; Kriskovich JO; Medina F; Gonzalez Arjol B; Brizuela M
    J Heart Lung Transplant; 2006 Oct; 25(10):1230-40. PubMed ID: 17045936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelin.
    Francia P; Salvati A; Balla C; De Paolis P; Pagannone E; Borro M; Gentile G; Simmaco M; De Biase L; Volpe M
    Eur J Heart Fail; 2007 Mar; 9(3):306-9. PubMed ID: 16891152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events.
    Sato Y; Nishi K; Taniguchi R; Miyamoto T; Fukuhara R; Yamane K; Saijyo S; Tanada Y; Yamamoto E; Goto T; Takahashi N; Fujiwara H; Takatsu Y
    J Cardiol; 2009 Oct; 54(2):221-30. PubMed ID: 19782259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine.
    Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B
    Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure.
    Tsutamoto T; Kawahara C; Yamaji M; Nishiyama K; Fujii M; Yamamoto T; Horie M
    Eur J Heart Fail; 2009 Jul; 11(7):653-8. PubMed ID: 19502379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of NT-proBNP and renal function in comparison to contemporary multi-marker risk scores in heart failure patients.
    Pfister R; Diedrichs H; Schiedermair A; Rosenkranz S; Hellmich M; Erdmann E; Schneider CA
    Eur J Heart Fail; 2008 Mar; 10(3):315-20. PubMed ID: 18304872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative role of NT-pro BNP and cardiac troponin T at 96 hours for estimation of infarct size and left ventricular function after acute myocardial infarction.
    Steen H; Futterer S; Merten C; Jünger C; Katus HA; Giannitsis E
    J Cardiovasc Magn Reson; 2007; 9(5):749-58. PubMed ID: 17891611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease in plasma B-type natriuretic peptide early after initiation of cardiac resynchronization therapy predicts clinical improvement at 12 months.
    Kubánek M; Málek I; Bytesník J; Frídl P; Riedlbauchová L; Karasová L; Lánská V; Kautzner J
    Eur J Heart Fail; 2006 Dec; 8(8):832-40. PubMed ID: 16546444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic role of highly sensitive cardiac troponin I in patients with systolic heart failure.
    Tsutamoto T; Kawahara C; Nishiyama K; Yamaji M; Fujii M; Yamamoto T; Horie M
    Am Heart J; 2010 Jan; 159(1):63-7. PubMed ID: 20102868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.